BioLineRx
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $477 | $195 | $427 | $304 |
Gross Profit | 382 | 91 | 343 | 232 |
EBITDA | -2,250 | -1,904 | -554 | -3,488 |
EBIT | -2,338 | -1,968 | -673 | -3,664 |
Net Income | -2,580 | -1,393 | -977 | -3,940 |
Net Change In Cash | 477 | 195 | 427 | 304 |
Free Cash Flow | -2,286 | -3,254 | -2,106 | -177 |
Cash | 2,504 | 3,249 | 7,914 | 7,189 |
Basic Shares | 4,433 | 4,351 | 3,949 | 3,949 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,189 | $28,940 | $4,800 | $0 |
Gross Profit | 430 | 19,677 | 1,108 | -654 |
EBITDA | -224 | 3,918 | -57,086 | -22,139 |
EBIT | -751 | -147 | -58,470 | -22,793 |
Net Income | -1,184 | -9,221 | -60,614 | -24,951 |
Net Change In Cash | 1,189 | 28,940 | 4,800 | 0 |
Free Cash Flow | -8,163 | -43,927 | -22,905 | -26,556 |
Cash | 3,249 | 10,436 | 4,255 | 10,587 |
Basic Shares | 4,108 | 79,873 | 64,224 | 51,597 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.58 |
2025-12-31 | -$0.32 |
2025-09-30 | -$0.22 |
2025-06-30 | -$1.01 |